Navigation Links
Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing
Date:12/4/2007

TM)) for gene modification. Sangamo has established strategic partnerships with companies outside of the human therapeutic space including Dow AgroSciences, Sigma-Aldrich and several companies applying its ZFP Technology to enhance the production of protein pharmaceuticals. For more information about Sangamo, visit the company's web site at http://www.sangamo.com.

This press release may contain forward-looking statements based on Sangamo's current expectations. These forward-looking statements include, without limitation, references to the research and development of novel ZFP TFs and ZFNs as ZFP Therapeutics, applications of Sangamo's ZFP TF technology platform, strategic partnerships with collaborators and clinical trials of ZFP Therapeutics. Actual results may differ materially from these forward-looking statements due to a number of factors, including technological challenges, uncertainties relating to the initiation and completion of stages of ZFP Therapeutic clinical trials, Sangamo's ability to develop commercially viable products and technological developments by our competitors. See the company's SEC filings, and in particular, the risk factors described in the company's Annual Report on Form 10-K and its most recent 10-Q. Sangamo BioSciences, Inc. assumes no obligation to update the forward-looking information contained in this press release.


'/>"/>
SOURCE Sangamo BioSciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sangamo BioSciences Presents Data Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
2. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
3. Sangamo BioSciences to Present at the 2007 BIO InvestorForum
4. Sangamo BioSciences Announces Third Quarter 2007 Conference Call and Webcast
5. Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting
6. Sangamo BioSciences to Present at the Piper Jaffray Health Care Conference
7. Sangamo BioSciences to Present at the BMO Capital Markets Health Care Conference
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
10. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
11. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2008)...5 /- Lentigen Corporation announced t... of Health (NIH) small,business innovation researc...ists. Through these grants, Lentigen will apply it... the development of novel,immunotherapeutic treatm...-- Melanoma, with Michael Nishimura, Ph.D, Associa...
(Date:5/15/2008)...any Focused on Commercialization in 2008 -, FREMO...llion, Inc.,(Nasdaq: VRML ), a molecular diagnost... the first quarter ended March 31, 2008, and provi...elopments., "During the first quarter of 2008, we...zation progress in each of our diagnostic programs...
(Date:5/15/2008)...ay 15 /- Nile Therapeutics,...results for the first quarter,ended March 31, 2008...08 was $3.1 million, or,$0.13 per share, compared ... quarter of 2007. Weighted average shares outstand...4.1 million and 13.8 million, respectively., Nile...
(Date:5/15/2008)... /- American Oriental,Bioen...mpany dedicated to,improving health through the de...broad range of prescription and over the counter (...wing statement regarding the earthquake in,China:,...,s earthquake and we,are thankful to report that n...
Breaking Biology Technology:Lentigen Corporation Receives Four Research Grants From the National Institutes of Health 2Vermillion Announces First Quarter 2008 Financial Results and Business Progress 2Vermillion Announces First Quarter 2008 Financial Results and Business Progress 3Vermillion Announces First Quarter 2008 Financial Results and Business Progress 4Vermillion Announces First Quarter 2008 Financial Results and Business Progress 5Vermillion Announces First Quarter 2008 Financial Results and Business Progress 6Vermillion Announces First Quarter 2008 Financial Results and Business Progress 7Vermillion Announces First Quarter 2008 Financial Results and Business Progress 8Vermillion Announces First Quarter 2008 Financial Results and Business Progress 9Nile Therapeutics Reports 2008 First Quarter Financial Results 2Nile Therapeutics Reports 2008 First Quarter Financial Results 3American Oriental Bioengineering Comments on Earthquake 2
...adison, Wis. - Jason Smith acknowledges he,s on a... Fund Midwest , a sector fund of the Peak Ridge Ca...idwest and the East Coast venture communities, and...n technology companies is one of the reasons that ...g and it is one of the first things I think about,...
...ilwaukee, Wis. - Broadlook Technologies , an Int...el, Gregory Meier, as the firm,s chief operations ...private equity, and venture capital sectors, and h...sed Broadlook grow through sales, marketing, and b...g, and he believed in our vision five years ago wh...
...adison, Wis. - A University of Wisconsin-Madison... students the fourth-fastest financial return in t...Best B-Schools " issue. , ,On average, the UW clas... earning salaries $42,343 higher than before. A gr...not counting lost income for full-time students. ,...
...have been closely following the progress of the H... (HIPAA) and electronic health records for the la...m a practicing dentist with a small healthcare bus...am what they call a "stakeholder" in this exciting...andate. , ,More important than my job, I am a hus...
Other Biology Technology:Investor links East Coast funds to Midwest tech 2Investor links East Coast funds to Midwest tech 3UW-Madison MBA program ranked among best for investment return 2Careful with that electronic health record, Mr. Leavitt 2Careful with that electronic health record, Mr. Leavitt 3Careful with that electronic health record, Mr. Leavitt 4
(Date:5/15/2008)... May 15, 2008 (BRONX, NY) Contrary to long-held... risk of death, according to investigators from th...niversity. They reached their conclusion after exa...ative sample of adults in the U.S. The Einstein re...sed risk of death from cardiovascular disease (CVD...
(Date:5/15/2008)... Argonne, Ill. (May 15, 2008) Argonne National L... (MOU) with Savannah River National Laboratory (SR...ntal management research projects in support of cr...r important national priorities. , "The MOU allo...search," Argonne director Robert Rosner said. "Arg...
(Date:5/15/2008)... Fishermen hold empirical knowledge that tuna agg...old rope, pieces of wood, or even large marine mam...aggregation behaviour, but the past 20 years have ...of the associated concentrations of fish. Fisherme...h act as FADs. An enormous purse-seine net, deploy...
(Date:5/14/2008)... Intelligent Wireless Module Combines Linux, Se... Consumption, TUSTIN, Calif., May 14 /PRNewswire/...n intelligent high-performance module designed for...tion to 802.11a/b/g wireless local,area networks (...at need,WLAN connectivity with minimal power usage...
Breaking Biology News(10 mins):New study casts further doubt on risk of death from higher salt intake 2Argonne-SRNL agreement supports critical DOE, national priorities 2Does fishing on drifting fish aggregation devices endanger the survival of tropical tuna? 2Does fishing on drifting fish aggregation devices endanger the survival of tropical tuna? 3New Silex SX-560 Enables Enterprise 802.11 Wireless Connectivity for Battery Operated Devices 2Wiley Blackwell renews carbon neutral commitment 12424 1Taking Multiple Pain Relievers May Cause Complications 12419 1Taking Multiple Pain Relievers May Cause Complications 12419 2Patients relatives are ignored by the health system and suffer emotional stress 12416 1Patients relatives are ignored by the health system and suffer emotional stress 12416 2Former Biolase CEO 26 EVP Launch Technology4Medicine 12411 1Former Biolase CEO 26 EVP Launch Technology4Medicine 12411 2
...ster may have answered one of neuroscience,s most ...which are responsible for our crystal-clear though...November issue of Nature Neuroscience, the Rochest...gly chaotic, or "noisy," signals to represent the ... dramatically enhances the brain,s processing, ena...
...ifts ?soldiers, pilots, truckers, students, doctor...research showing that preventing the gas nitric ox... sleep urge. , The research, conducted by investi...versity of Helsinki (Helsinki, Finland), ties toge...hat nitric oxide production in a specific region o...
...red out how one particular protein contributes to ...gs longer than an hour or two. The findings are re.... , The protein, called Arc, has been implicated i...ng in birds to rodents being aware of 3-D space. I...ng-term memory-based behaviors like drug addiction...
...d MIT have engineered yeast that can improve the s...omponent to making biofuels a significant part of ... additive to improve gasoline combustibility, etha... growing oil-driven energy crisis. But there are s...that high ethanol levels are toxic to the yeast th...
Other Biology News:Mysterious 'neural noise' actually primes brain for peak performance 2Mysterious 'neural noise' actually primes brain for peak performance 3Need to pull an all-nighter? 2Hopkins researchers discover how brain protein might control memory 2Hopkins researchers discover how brain protein might control memory 3Engineered yeast speeds ethanol production 2
Agarose, high EEO, Molecular Biology Grade from Research Organics, Inc.
The 12-Tube Magnetic Separation Rack is designed to be used for small-scale separations using magnetic particles. ,Capacity: 12 microcentrifuge tubes. ,Magnets: Neodymium rare earth permanent ma
Single Place Magnetic Stand from Ambion
Full-length cDNA 5-PRIME end of clone CS0DE013YM09 of Placenta of Homo sapiens (human). [Source:Uniprot/SPTREMBL;Acc:Q86TS7] Antigen: Recombinant Protein Epitope Signature Tag (PrEST).
Biology Products: